Canopus BioPharma Incorporated

CBIA · OTC
Analyze with AI
$0.0001+$0.00 (+0%)
At close:Dec 18, 2025, 9:00 PM UTC
$0.0001+$0.00 (+0%)
After hours:Dec 18, 2025, 9:00 PM UTC
P/E TTM-0.01
P/B TTM-0.83
P/S TTM0
Dividend Yield0%
EPS–
Beta8.278275
Valuation
PEG Ratio-0.00
FCF Yield-1.36%
EV / EBITDA-0.60
More On Valuation »
Quality
ROIC25,400.66%
Gross Margin0.00%
Cash Conv. Ratio0.07
More On Quality »
Growth
Revenue 3Y CAGR–
FCF Growth-252.14%
More On Growth »
Safety
Net Debt / EBITDA-0.01
Interest Coverage-5,272.83
More On Safety »
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle0.00
More On Efficiency »

Canopus BioPharma Incorporated (CBIA) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Canopus BioPharma Incorporated (CBIA) stock price today?

As of Dec 18, 2025, 9:00 PM UTC, Canopus BioPharma Incorporated (CBIA) stock is trading at $0.0001. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CBIA stock quotes for informed trading decisions.

What is Canopus BioPharma Incorporated's market capitalization?

Canopus BioPharma Incorporated (CBIA) has a market capitalization of approximately $455.1K. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Canopus BioPharma Incorporated's size relative to other companies in the USD market. The market cap figure updates automatically as the CBIA stock price changes.

What is the 52-week range for Canopus BioPharma Incorporated stock?

Canopus BioPharma Incorporated (CBIA) stock has traded in a 52-week range of $0.00 — $0.0002. The 52-week range shows the highest and lowest prices at which CBIA traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Canopus BioPharma Incorporated stock price to this range provides context for recent price action.

How much trading volume does Canopus BioPharma Incorporated stock have?

Canopus BioPharma Incorporated (CBIA) stock recently traded approximately 5.1M shares. Trading volume indicates market liquidity and investor interest in CBIA. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Canopus BioPharma Incorporated stock.

Does Canopus BioPharma Incorporated pay dividends to shareholders?

Yes, Canopus BioPharma Incorporated (CBIA) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Canopus BioPharma Incorporated stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Canopus BioPharma Incorporated's intraday price range?

Today, Canopus BioPharma Incorporated (CBIA) stock has traded in a range of $0.0001 — $0.0001. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CBIA's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Canopus BioPharma Incorporated stock data?

AlphaPilot sources real-time CBIA stock quotes, fundamental financial data, and historical price charts for Canopus BioPharma Incorporated from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Canopus BioPharma Incorporated stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CBIA stock performance.